T-helper-1 and T-helper-2 Responses in Psychiatric Disorders

By Schwarz M.J.   Chiang S.   Müller N.   Ackenheil M.  

Brain, Behavior, and Immunity, Vol. 15, Iss. 4, 2001-12 ,pp. : 340-370

Academic Press

Access to resources Recommend Favorite

Differential response to treatment of relapsing–remitting multiple sclerosis with IFN-&bgr;: is there a dichotomy into T-helper-1 and -17 driven disease?

By Weissert Robert  

Future Neurology, Vol. 5, Iss. 4, 2010-07 ,pp. : 481-484

Future Medicine

Access to resources Recommend Favorite

Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis

By Zipp F   Kerschensteiner M   Dornmair K   Malotka J   Schmidt S   Bender A   Giegerich G   de Waal Malefyt R   Wekerle H   Hohlfeld R  

Brain, Vol. 121, Iss. 8, 1998-08 ,pp. : 1395-1407

Oxford University Press

Access to resources Recommend Favorite

Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis

By Neumann Helmut   Csepregi Antal   Sailer Michael   Malfertheiner Peter  

Journal of Neurology, Vol. 254, Iss. 6, 2007-06 ,pp. : 816-817

Springer Publishing Company

Access to resources Recommend Favorite

Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo

By Weber Martin S.  

Brain, Vol. 127, Iss. 6, 2004-06 ,pp. : 1370-1378

Oxford University Press

Access to resources Recommend Favorite